Literature DB >> 17197022

Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.

Nozomi Niitsu1, Masataka Okamoto, Naoya Nakamura, Hirokazu Nakamine, Sadao Aoki, Masami Hirano, Ikuo Miura.   

Abstract

Rearrangements involving the BCL6 gene are found in 30% of diffuse large B-cell lymphomas (DLBCLs). We evaluated the clinical characteristics and prognoses of patients with B-cell lymphoma carrying 3q27 translocations. Among the 59 patients having 3q27 translocation, 10.9% had follicular lymphoma (FL) and 23.1% had DLBCL. It is of interest that the prognostic significance was not found between FL and DLBCL with 3q27 translocations. Progression-free survival (PFS) rate was significantly higher in the FL patients with 3q27 translocation than in those with 18q21 translocation. PFS rate was significantly higher in the DLBCL patients with 3q27 translocation than in those with 18q21 translocation. These findings suggest that the presence of 3q27 translocation is a significant prognostic factor in DLBCL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197022     DOI: 10.1016/j.leukres.2006.11.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  BCL6 Rearrangement Indicates Poor Prognosis in Diffuse Large B-cell Lymphoma Patients: A Meta-analysis of Cohort Studies.

Authors:  Shu Li; Zhan Wang; Liming Lin; Zhaoxing Wu; Qingfeng Yu; Feiqiong Gao; Jiawei Zhang; Yang Xu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

2.  Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.

Authors:  Yunshu Zhu; Sheng Yang; Xiaohui He
Journal:  J Endocrinol Invest       Date:  2021-12-04       Impact factor: 5.467

3.  Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.

Authors:  Carmen Bellas; Diego García; Yolanda Vicente; Linah Kilany; Victor Abraira; Belen Navarro; Mariano Provencio; Paloma Martín
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.